Jackson Creek Investment Advisors LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Jackson Creek Investment Advisors LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$797
+6.7%
68,210
+51.5%
0.34%
+7.7%
Q1 2023$747
-42.1%
45,033
-35.0%
0.31%
-45.4%
Q4 2022$1,290
-99.9%
69,333
-3.6%
0.57%
+32.6%
Q3 2022$923,000
-29.3%
71,938
-43.6%
0.43%
-18.2%
Q2 2022$1,306,000
+14.2%
127,503
-7.6%
0.53%
+26.3%
Q1 2022$1,144,000137,9390.42%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders